Tag Archives: TNM

BaiJiaYun Limited Announces Completion of Merger and New Board and Management

BEIJING, Dec. 24, 2022 /PRNewswire/ — BaiJiaYun Limited (“BaiJiaYun”) today announced the successful completion of the transaction (the “Transaction”) previously announced on July 19, 2022 between BaiJiaYun and Fuwei Films (Holdings) Co., Ltd. (“Fuwei Films” or the “Company”). As announced on September 26, 2022, the Transaction and certain additional Transaction-related proposals were approved by Fuwei Films’ shareholders at an extraordinary general meeting held on September 24, 2022 (the “EGM”). Among such proposals, the Company’s name will be changed from “Fuwei Films (Holdings) Co., Ltd.” to “ Baijiayun Group Ltd“. The Company continues to be listed on Nasdaq and its ticker is expected to be changed from “FFHL” to “RTC”.

Completion of Transaction

Pursuant to the Agreement and Plan of Merger, dated July 18, 2022, by and between Fuwei Films and BaiJiaYun (the “Merger Agreement”), at the closing of the Transaction (the “Closing”), the then shareholders of BaiJiaYun exchanged all of the issued and outstanding share capital of BaiJiaYun for newly issued shares of the Company on the terms and conditions set forth in the Merger Agreement. As a result of the Transaction, BaiJiaYun has become a wholly-owned subsidiary of the Company. Immediately prior to the Closing, the third amended and restated memorandum of association and the second amended and restated articles of association of the Company, as approved at the EGM, became effective. Immediately after the Closing, the securities issued and outstanding of the Company will be: (i) 29,201,849 class A ordinary shares, (ii) 54,583,957 class B ordinary shares, and (iii) warrants to subscribe for 17,964,879 class A ordinary shares.

In connection with the Transaction, Linklaters served as legal counsel to BaiJiaYun.

Name and Ticker

As approved at the EGM, the Company’s name will be changed from “Fuwei Films (Holdings) Co., Ltd.” to “Baijiayun Group Ltd ” effective from the date of entry of the new name in place of the existing name of the Company on the register of companies maintained by the Registrar of Companies in the Cayman Islands. The ticker of the Company is expected to be changed from “FFHL” to “RTC”.

New Board and Management

The Company’s board of directors (the “Board”) and management currently consist of the following members, effective upon the Closing in accordance with the Merger Agreement:

  • Mr. Gangjiang Li, the founder of BaiJiaYun, has been appointed the chairman of the Board, the Company’s chief executive officer, and the chairperson of the compensation committee of the Board.
  • Mr. Yi Ma, previously a director of BaiJiaYun, has been appointed a director and the president of the Company and the chairperson of the nominating and corporate governance committee of the Board.
  • Mr. Chun Liu has been appointed an independent director of the Company, a member of the audit committee of the Company and a member of the compensation committee of the Board.
  • Mr. Erlu Lin has been appointed an independent director of the Company, the chairperson of the audit committee of the Board and a member of the nominating and corporate governance committee of the Board.
  • Mr. Lei Yan, previously the chief executive officer and chairman of the Board of Fuwei Films, has been appointed a director of the Company.
  • Mr. Yong Fang has been appointed the chief financial officer of the Company.

Ms. Jingjing Cheng, previously the chief financial officer and a director of Fuwei Films, Mr. Tee Chuang Khoo, Mr. Junying Liu, and Mr. Lihang Geng, each previously an independent director of Fuwei Films, have all resigned from their respective roles.

About Baijiayun Group Ltd 

Baijiayun Group Ltd and its subsidiaries (“Baijiayun Group”) is a video-centric technology solution provider with core expertise in SaaS/PaaS solutions. Baijiayun Group is committed to delivering reliable, high-quality video experiences across devices and localities and have grown rapidly since the inception in 2017. Premised on its industry-leading video-centric technologies, Baijiayun Group offers a wealth of video-centric technology solutions including Video SaaS/PaaS, Video Cloud and Software, Video AI and System Solutions. Baijiayun Group is catered to the evolving communications and collaboration needs of enterprises of all sizes and industry, which makes Baijiayun Group a one-stop video technology solution provider.

Safe Harbor Statement

This press release contains certain “forward-looking statements.” These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the parties’ perspectives and expectations, are forward-looking statements. The words “will,” “expect,” “believe,” “estimate,” “intend,” “plan” and similar expressions indicate forward-looking statements.

Such forward-looking statements are inherently uncertain, and shareholders and other potential investors must recognize that actual results may differ materially from the expectations as a result of a variety of factors. Such forward-looking statements are based upon management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which are hard to predict or control, that may cause the actual results, performance, or plans to differ materially from any future results, performance or plans expressed or implied by such forward-looking statements. The forward-looking information provided herein represents the Company’s estimates as of the date of this press release, and subsequent events and developments may cause the Company’s estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release.

A further list and description of risks and uncertainties can be found in the proxy statement filed as exhibit 99.2 to the Form 6-K on August 22, 2022, and other documents that the parties have filed or furnished, or may file or furnish with the SEC, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and the Company, BaiJiaYun and their subsidiaries and affiliates undertake no obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.

Cision View original content:https://www.prnewswire.com/news-releases/baijiayun-limited-announces-completion-of-merger-and-new-board-and-management-301709753.html

CCV’s Portfolio Perfect Corp. and Provident Acquisition Corp. Complete Business Combination

  • Perfects Shares and Warrants to Trade on the NYSE under Ticker Symbols PERF” and PERF WS” respectively

BEIJING, Nov. 1, 2022 /PRNewswire/ — CCV’s early-stage portfolio company Perfect Corp. (“Perfect”), a global leader in providing augmented reality (“AR”) and artificial intelligence (“AI”) Software-as-a-Service (“SaaS”) solutions to beauty and fashion industries, and Provident Acquisition Corp. (Nasdaq: PAQC; “Provident”), a special purpose acquisition company, today announced the completion of their previously announced business combination (the “Business Combination”).

The listed company resulting from the Business Combination will be called Perfect Corp, and its shares and warrants will commence trading on the New York Stock Exchange under the ticker symbols “PERF” and “PERF WS” respectively, on October 31, 2022.

Perfect is also the second IPO that the CCV team has harvested since Arrail Dental (HKSE:6639) was listed in Hong Kong Stock Exchange earlier this year.

Perfect is the market leader in the global beauty tech sector, with over 400 beauty brands, including 17 of the world’s top global 20 beauty groups, utilizing Perfect’s AR and AI SaaS solutions in 80 countries globally, as of December 31, 2021, according to Frost & Sullivan.

The PIPE transaction is backed by blue-chip investors including CHANEL, CyberLink, Shiseido, and Snap as well as reputable financial investors. 

Wei Zhou, the founding and managing partner of CCV, was impressed by Alice and her team in their first meeting. “I’ve always believed in Alice and her team to make history and we think Perfect will continue to achieve greatness in the global market,” said Wei.

CCV devotes to early-stage investments in AI technology. Besides Perfect Corp, CCV has also invested in other leading AI companies, such as Shukun Technology, a leading AI medical company that focuses on diagnostic systems for chronic diseases; Quicktron, an AI robotics company that focuses on intelligent warehouse robotics and logistics systems.

About CCV

CCV is a leading venture capital firm focusing on early-stage investment and committed to supporting technology-driven innovation.  Founded by former KPCB China managing partner Zhou Wei and the original technology investment team at KPCB, CCV manages 750 million USD and 2.5 billion RMB.

CCV team has achieved a 35% unicorn hit rate track record, and its investment portfolio continues to yield at least one unicorn every year. Many CCV’s portfolio companies have become the first IPO stock in their respective focused areas. CCV is the A-round leading investor in 80% of its investments.

CCV’s star portfolios include JD.com (NASDAQ:JD), Venus Tech (SZSE:002439), CreditEase (NYSE:YRD), COL Group (SHSE:300364), Rong 360 (NYSE:JT), TanTan (acquired by NASDAQ:MOMO), Shukun Technology, Perfect Corp(NYSE: PERF), JD Digital, Ximalaya FM, Transsnet Financial, MetaApp, U POWER, Cowa Robot, Naxions, IceKredit etc.

Cision View original content:https://www.prnewswire.com/news-releases/ccvs-portfolio-perfect-corp-and-provident-acquisition-corp-complete-business-combination-301663481.html

AIOps Provider ScienceLogic Acquires Machine Learning Analytics Provider Zebrium to Provide At-A-Glance Root Cause Visibility


RESTON, Va., Oct. 12, 2022 /PRNewswire/ — Moving toward its goal of freeing up resources of enterprise IT teams and optimizing digital experiences, AIOps and hybrid-cloud IT management provider ScienceLogic has acquired machine learning analytics firm Zebrium to automatically find the root cause of complex, modern (i.e., containerized, cloud-native) application problems. This partnership drastically reduces the time it takes to identify, diagnose and resolve business-service impacting issues, lowering IT costs and delivering superior customer and employee experiences.

How? With this acquisition, ScienceLogic is combining its AIOps capabilities with the root-cause analysis (RCA) technology of Zebrium to provide enterprises with the ability to comprehensively understand their IT estate, from endpoint devices to SaaS and cloud environments. The solution provides powerful machine learning analytics that draw on both real-time and historical data for a contextual understanding of the service impact and root cause when issues arise so they can be automatically remediated.

“We understand that at the end of the day, customers care about a few core things. Among those are making sense of drastically increased amounts of data, maintaining a quick time to resolution, and focusing on customer experience,” says Mike Nappi, CPO at ScienceLogic. “Combining our capabilities with that of Zebrium creates a whole new level of analytics-driven insights and automation we can bring to bear for our customers.”

“This partnership means that ITOps and DevOps teams will have the breathing room to commit time, energy, and resources to improving and supporting infrastructure and analytics standards, all while cutting IT costs,” said Ajay Singh, CEO at Zebrium. “With our machine learning capabilities combined with ScienceLogic’s service context and automation, organizations can greatly reduce the time they spend identifying and remediating issues.”

“The Cisco Technical Assistance Center (TAC) spends thousands of hours each month analyzing software logs to find the root cause of customer incidents,” said Koree Mires, Director, Global TAC Innovation, Automation and Disruption at Cisco Systems. “We had been investigating ways to help automate this process for many years. When we came across Zebrium, we were immediately impressed. In order to validate its effectiveness, we tested RCaaS with four product lines and 192 actual customer incidents. We were astonished to find that RCaaS correctly found the root cause automatically over 95 percent of the time.”

To learn more about ScienceLogic and Zebrium’s partnership, please contact:

Jillian Dykhouse
Sr. Content Marketing Manager
214-449-6909
jillian.dykhouse@sciencelogic.com 

Or visit our Newsroom at https://sciencelogic.com/about/news.

About ScienceLogic

ScienceLogic empowers intelligent automated IT operations freeing up IT talent, accelerating innovation and transformation, and driving outcomes. ScienceLogic’s AIOps platform monitors customer data across clouds and on-premises, enabling digital service visibility and automation. Trusted by thousands of organizations across the globe, ScienceLogic’s technology meets the rigorous security requirements of the U.S. DOD, has been proven for scale by the world’s largest service providers, and is optimized to meet the needs of large enterprises and government agencies. https://sciencelogic.com

Logo – https://techent.tv/wp-content/uploads/2022/10/aiops-provider-sciencelogic-acquires-machine-learning-analytics-provider-zebrium-to-provide-at-a-glance-root-cause-visibility.jpg

ReneSola Power Announces Acquisition of Emeren

STAMFORD, Conn., Oct. 11, 2022 /PRNewswire/ — ReneSola Ltd (“ReneSola Power” or the “Company”) (www.renesolapower.com) (NYSE: SOL), a leading fully integrated solar project developer, today announced the acquisition of Emeren Limited (“Emeren”), a United Kingdom-based utility-scale solar power and battery projects developer in Europe. The acquisition transaction was completed on October 10 through an all-cash deal with an earn-out provision.

Emeren is currently comprised of over 22 employees and has been a strategic partner of Renesola Power to co-develop ground-mounted solar and storage projects in Italy since 2021. Emeren has over 2.5 GW of pipeline under development (at different development stages) including over 2 GW of solar projects and over 500 MW of storage projects.

Mr. Yumin Liu, ReneSola Power Chief Executive Officer, said, “ReneSola Power is committed to accelerating solar development in Europe, the largest market in our global presence. The timing of this acquisition is excellent as it increases our project pipeline in Europe at a time when solar power purchase agreement prices have increased dramatically due to a supply shortage and favorable regulatory conditions. Further, the prestigious reputation, financial profile, and industry experience of Emeren are valuable assets to ReneSola Power as we expand our business footprint into Italy and other European countries. The acquisition is expected to generate healthy EBITDA immediately.”

Guido Prearo, CEO of Emeren, added, “I’m very excited about this acquisition as it offers unique synergies. ReneSola Power’s significant project development expertise and resources will enable us to grow stronger and more dynamic and benefit our partners and trusted clients. At the same time, we bring in-depth knowledge of the Italian market and other key European solar markets. I am confident we will achieve our solar development and storage milestones in the next few years and contribute significantly to ReneSola Power’s long-term growth.”

About ReneSola Power

ReneSola Power (NYSE: SOL) is a leading global solar project developer and operator. The Company focuses on solar power project development, construction management and project financing services. With local professional teams in more than 10 countries around the world, the business is spread across number of regions where the solar power project markets are growing rapidly and can sustain that growth due to improved clarity around government policies. The Company’s strategy is to pursue high-margin project development opportunities in these profitable and growing markets; specifically, in the U.S. and Europe, where the Company has a market-leading position in several geographies, including Poland, Hungary, Minnesota and New York. For more information, please visit www.renesolapower.com.

About Emeren Limited

Emeren is a developer of utility-scale solar power and battery storage projects with a geographically diversified pipeline in various stages of development. Currently, the Company has over 2.5GW of projects under development (mid- to early- stage), all backed by institutional investors’ capital. Emeren has leveraged on trusted partnerships with tier-1 international financial and industrial players in order to deploy top-notch financial solutions. For additional information about the Company, follow Emeren on LinkedIn or visit www.emeren.co.uk.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/renesola-power-announces-acquisition-of-emeren-301645442.html

Source: ReneSola Ltd.

ReneSola Power Acquires 50 MWp Fully Operational Solar Farm in the United Kingdom and Commences its IPP business in Europe

STAMFORD, Conn., Sept. 30, 2022 /PRNewswire/ — ReneSola Ltd (“ReneSola Power” or the “Company”) (www.renesolapower.com) (NYSE: SOL), a leading fully integrated solar project developer, today announced that it acquired a 50 MWp operational solar farm (“Project Branston”) located in Branston, Lincoln, United Kingdom from P&T Global Renewable Energy LTD. The transaction was completed on September 30, 2022. Project Branston’s 50 MWp solar farm has been operational since October 12, 2020 and is currently generating a highly attractive annualized yield of 1,011 MWh/MWp.

Mr. Yumin Liu, ReneSola Power Chief Executive Officer, said, “We are extremely excited to commence our asset-light, IPP business in Europe with the acquisition of Project Branston. This fully operational solar farm will be profitable on day one and provides stable cash flows and helps diversify risks from project sales. We anticipate the acquisition to further strengthen our market position in the Europe and will be accretive to our shareholders. This will be a new chapter of our company to enter into IPP business in Europe and contribute to energy alleviation of Europe energy crisis.”

About ReneSola Power

ReneSola Power (NYSE: SOL) is a leading global solar project developer and operator. The Company focuses on solar power project development, construction management and project financing services. With local professional teams in more than 10 countries around the world, the business is spread across number of regions where the solar power project markets are growing rapidly and can sustain that growth due to improved clarity around government policies. The Company’s strategy is to pursue high-margin project development opportunities in these profitable and growing markets; specifically, in the U.S. and Europe, where the Company has a market-leading position in several geographies, including Poland, Hungary, Minnesota and New York. For more information, please visit www.renesolapower.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/renesola-power-acquires-50-mwp-fully-operational-solar-farm-in-the-united-kingdom-and-commences-its-ipp-business-in-europe-301637792.html

Source: ReneSola Ltd.

WeLab and Astra Complete the Acquisition of Bank Jasa Jakarta

Plans to Transform the Bank into Indonesia’s Innovative Digital Bank

  • WeLab and Astra now jointly control the bank, with a total share ownership of approximately 99.13% of BJJ
  • All relevant regulatory approvals have been obtained, including from the Financial Services Authority (OJK) of Indonesia
  • This transaction is Southeast Asia’s largest digital bank M&A transaction in 2022

HONG KONG, Sept. 19, 2022 /PRNewswire/ — WeLab, a leading pan-Asian fintech platform, today announced the completion of the acquisition of an Indonesian commercial bank, PT Bank Jasa Jakarta (BJJ), together with PT Astra International Tbk (Astra), one of Indonesia’s largest public companies. The completion is marked by the issuance of acquisition approval by the Financial Services Authority (OJK). For this transaction, a WeLab-led consortium, Welab Sky Limited (WeLab Sky), participated in the acquisition together with Astra’s subsidiary PT Sedaya Multi Investama (Astra Financial). The WeLab-led consortium has drawn wide-spread support from existing and new investors, including Allianz X, Boyu Capital, Horizons Ventures, SCBX Group[1] and TFB (Taipei Fubon Bank) Capital.

In December 2021, WeLab entered into a Share Purchase and Subscription Agreement with the shareholders of BJJ, and completed a strategic investment for 24% of BJJ. With the acquisition completed today, WeLab and Astra each holds 49.56% of BJJ shares, becoming the majority shareholders and joint controllers of the bank. The transaction is Southeast Asia’s largest digital bank M&A transaction in 2022, illustrating the substantial commitment to invest in, and contribute to digitizing Indonesia’s banking industry. The shareholders aim to transform BJJ into an innovative digital bank in Indonesia.

Simon Loong, Founder and Group CEO of WeLab, said, “Expanding WeLab’s digital banking presence across Asia, first in Hong Kong and now in Indonesia, has been one of our key strategic moves. This partnership with Astra reinforces WeLab’s strategic focus on enhancing cross-country and business synergies with partners to increase scale and reach, in order to further strengthen the breadth and depth of the existing pan-Asian fintech platform. We’re excited that our long-term partner, Astra will be collaborating with us to deliver the best tech-driven banking services through BJJ in Indonesia. We look forward to bolstering the customer trust level with the collaboration with Astra.”

President Director of Astra Djony Bunarto Tjondro said, “Investment in BJJ is in line with Astra aspirations in financial services pillars to become leading retail financial providers in Indonesia and support the growth of financial services industry as well as the economy of Indonesia.”

Propel growth and digital innovation with strong synergies between Astra and WeLab

WeLab and Astra are long time partners in Indonesia’s fintech ecosystem. This is WeLab’s second strategic partnership initiative with Astra since the formation of a fintech lending joint venture, PT Astra WeLab Digital Arta (AWDA), in 2018. The complementary strengths of the partners, including WeLab’s know-how and technology in building and being an operator in digital banking, together with Astra’s solid business ecosystem and experience as well as vast distribution network, are highly synergistic and key success factors to propel BJJ’s digital transformation and into an innovative digital bank to serve the digital financial needs of Indonesians with accessible and innovative banking solutions.

Address unmet financial needs and advocate financial inclusion  

The prospect of digital banking in Indonesia is currently on the rise and represents a huge opportunity to provide accessible and innovative digital banking solutions, especially to the retail and MSMEs (Micro, Small & Medium Enterprises) segments. The utilization of financial services in Indonesia has the potential to grow, as 77% of Indonesia’s 270-million-population is either underbanked or unbanked. The country also has a sizable population of 180 million tech-savvy younger consumers, representing a great demand for digital banking services. 

[1] SCBX Group consists of Siam Commercial Bank PCL, which is a subsidiary of SCBX PCL

About WeLab 

WeLab, a leading pan-Asian fintech platform, operates WeLab Bank as well as multiple online financial services with leading positions in Hong Kong, Mainland China, and Indonesia, with more than 50 million individual users and over 700 enterprise customers. WeLab uses game-changing technology to help customers access credit, save money, and enjoy their financial journey.

Powered by proprietary risk management technology, patented privacy computing techniques, and advanced AI capabilities, WeLab offers mobile-based consumer financing solutions and digital banking services to retail individuals and technology solutions to enterprise customers.

WeLab operates in three markets under multiple brands, including WeLend, and WeLab Bank in Hong Kong, various business lines in Mainland China, Maucash and a digital bank in Indonesia.

WeLab is backed by the most renowned investors including Allianz, China Construction Bank International, International Finance Corporation (a member of the World Bank Group), CK Hutchison’s TOM Group, and Sequoia Capital.

To learn more, please visit: www.welab.co, or follow WeLab on LinkedIn and Facebook.

About Astra:

Astra is one of Indonesia’s largest public companies, comprising 240 subsidiaries, joint ventures, and associate companies, supported by nearly 190,000 employees. The company’s diversified business model creates synergies and opportunities across industry sectors including automotive, financial services, heavy equipment, mining construction and energy, agribusiness, infrastructure and logistics, information technology, and property. The company has a new sustainability framework which contains Astra 2030 Sustainability Aspirations. It will guide Astra in the transition journey to be a more sustainable business by  2030 and beyond. Astra wishes to contribute to the strength and resilience of the Indonesian economy while supporting an inclusive and prosperous society.

Astra has a strong record of public and social contributions through four pillars, which consist of health, education, environment, and entrepreneurships as well as nine foundations to contribute to the growth of the Indonesian economy while encouraging a more inclusive and prosperous society. Established in 2010, Astra’s Semangat Astra Terpadu Untuk (SATU) Indonesia Awards programme, has recognised the contribution of 493 young Indonesians across each of these focus areas, including 81 national level recipients and 412 provincial level recipients. The SATU Indonesia Awards programme is integrated with Astra’s wide range of community activities through 170 Kampung Berseri Astra and 1,060 Desa Sejahtera Astra initiatives in 34 provinces throughout Indonesia.

For more about Astra, visit www.astra.co.id & www.satu-indonesia.com and follow us on Instagram (@SATU_Indonesia), YouTube (SATU Indonesia), Facebook (Semangat Astra Terpadu) and Twitter (@SATU_Indonesia).

Nature’s Miracle, a Leader in the Controlled Environment Agriculture Industry, to be Listed on Nasdaq Through Business Combination with Lakeshore Acquisition II Corp.

  • Nature’s Miracle is a fast-growing agriculture technology company providing services to growers in Controlled Environment Agriculture (“CEA”) settings in North America;
  • Nature’s Miracle provides hardware as well as software to design, build and operate various indoor growing settings including greenhouse, vertical farming and indoor-growing spaces;
  • Nature’s Miracle, through its two wholly-owned subsidiaries, Visiontech Group, Inc. and Hydroman, Inc., provides grow lights as well as other hydroponic products to hundreds of indoor growers in North America;
  • Nature’s Miracle has also developed a robust pipeline to build commercial-scale greenhouse in the U.S. and Canada to meet the growing needs of fresh and local vegetable products. The Company offers turnkey solutions to its operating partners by providing design, construction and hardware installment services;
  • Nature’s Miracle has established its first manufacturing footprint in North America with its grow-light assembly plant in Manitoba, Canada and is expecting to set up additional manufacturing/assembly facilities in North America;
  • The implied pro-forma enterprise value of the combined company is approximately $265 million, assuming no redemptions from the trust account. The business combination is expected to be completed in the first quarter of 2023;
  • This transaction is expected to accelerate Nature’s Miracle’s development of commercial greenhouse in the U.S. and Canada.

UPLAND, Calif., Sept. 10, 2022 /PRNewswire/ — Nature’s Miracle Inc. (“Nature’s Miracle”), a leader in the Controlled Environment Agriculture Industry, and Lakeshore Acquisition II Corp. (“together with its successors, Lakeshore”) (Nasdaq: LBBB) today announced that they have entered into a definitive business combination agreement (the “Merger Agreement”). Upon closing, the combined company is expected to change its name to Nature’s Miracle Holding Inc. and its common stock is expected to be traded on the Nasdaq Global Market.

Management Comments

“In the face of global energy shortage, food security, drought and life-style change, Nature’s Miracle is excited to offer an alternative farming mode which saves transportation cost, reduces irrigation water requirements by up to 90% and ensures fresh and local supply of produces for health-conscious consumers. We have developed a robust pipeline of greenhouse projects in the U.S. and Canada for the next twenty-four months,” said Tie “James” Li, Founder, Chairman and Chief Executive Officer of Nature’s Miracle. “By combining with Lakeshore, Nature’s Miracle will be able to tap into the public equity and debt market to fund its aggressive growth plan going forward. We look forward to working with Lakeshore team to complete the transaction and to list on Nasdaq.”

“We are thrilled to partner with Nature’s Miracle on its public company journey,” said Bill Chen, Chairman and Chief Executive Officer of Lakeshore. “After learning of Nature’s Miracle’s business model and its position in the rapidly growing Controlled Environment Agriculture market, we immediately realized the vast potential for the Company’s growth in this very important market segment.”

Key Transaction Terms

Pursuant to the Merger Agreement, Nature’s Miracle will merge with LBBB Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of Lakeshore (the “Merger”), with Nature’s Miracle surviving and Lakeshore acquiring 100% of the equity securities of Nature’s Miracle. In exchange for their equity securities, the stockholders of Nature’s Miracle (the “Company Stockholders”) will receive an aggregate number of shares of common stock of Lakeshore (the “Merger Consideration”) with an aggregate value equal to: (a) two hundred thirty million U.S. dollars ($230,000,000), minus (b) any Closing Net Indebtedness (as defined in the Merger Agreement).

The Merger has been approved by the boards of directors of each of Lakeshore and Nature’s Miracle. The Merger will require the approval of the stockholders of Lakeshore and Nature’s Miracle and is subject to other customary closing conditions, including a registration statement on Form S-4 being declared effective by the U.S. Securities and Exchange Commission. The transaction is expected to close in the first quarter of 2023.

Advisors

Hunter Taubman Fischer & Li LLC. is acting as legal advisor to Nature’s Miracle and Loeb & Loeb is acting as legal advisor to Lakeshore. Maxim Group is acting as M&A advisor to Lakeshore.

Management Presentation

A presentation made by the management teams of both Nature’s Miracle and Lakeshore regarding the transaction will be available on the websites of Nature’s Miracle at https: //www.Nature-Miracle.com and Lakeshore at https://www.lakeshoreacquisition.com/tzzy. Lakeshore will also file the presentation with the SEC in a Current Report on Form 8-K, which will be accessible at www.sec.gov.

About Lakeshore Acquisition II Corp.

Lakeshore Acquisition II Corp. is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.

About Nature’s Miracle Holdings Inc.

Nature’s Miracle is a fast-growing agriculture technology company providing services to growers in the Controlled Environment Agriculture (“CEA”) industry which also include vertical farming in North America. The Company offers integrated solutions which include hardware as well as software to design, build and operate various indoor growing settings including greenhouse and indoor-growing spaces. Nature’s Miracle, through its two wholly-owned subsidiaries, Visiontech Group, Inc. and Hydroman, Inc., provides grow lights as well as other hydroponic products to hundreds of indoor growers in North America. Nature’s Miracle has also developed a robust pipeline to build commercial-scale greenhouse in the U.S. and Canada to meet the growing needs of fresh and local vegetable products. The Company offers turnkey solutions to its operating partners by providing the design, construction and hardware installment services; Nature’s Miracle has established its first manufacturing footprint in North America with its grow-light assembly plant in Manitoba, Canada and is expected to set up additional manufacturing/assembly facilities in North America.  

Important Information About the Proposed Business Combination and Where to Find It

This press release relates to a proposed business combination between Lakeshore and Nature’s Miracle. A full description of the terms of the business combination will be provided in a Registration Statement on Form S-4 and proxy statement to be filed with the SEC by Lakeshore. The proxy statement will be mailed to Lakeshore’s shareholders as of a record date to be established for voting at the shareholders’ meeting relating to the proposed transactions. This press release does not contain all the information that should be considered concerning the proposed business combination and is not intended to form the basis of any investment decision or any other decision in respect of the proposed business combination. Lakeshore’s shareholders and other interested persons are advised to read, when available, the Registration Statement on Form S-4 and proxy statement and the amendments thereto and other documents filed in connection with the proposed business combination, as these materials will contain important information about Nature’s Miracle, Lakeshore and the proposed business combination. The Registration Statement on Form S-4 and the proxy statement and other documents filed with the SEC, once available, may be obtained without charge at the SEC’s website at www.sec.gov, or by directing a written request to Lakeshore, 667 Madison Avenue, New York, NY 10065.

Participants in the Solicitation

Lakeshore, certain shareholders of Lakeshore, and their respective directors and executive officers may be deemed participants in the solicitation of proxies from Lakeshore’s shareholders with respect to the proposed business combination. A list of the names of Lakeshore’s directors and executive officers and a description of their interests in Lakeshore is contained in Lakeshore’s registration statement on Form S-1, which was filed with the SEC and is available free of charge at the SEC’s web site at www.sec.gov, or by directing a written request to Lakeshore, 667 Madison Avenue, New York, NY 10065. Additional information regarding the interests of such participants will be contained in the Registration Statement on Form S-4 and proxy statement for the proposed business combination when available.

Nature’s Miracle and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the shareholders of Lakeshore in connection with the proposed business combination. A list of the names of such directors and executive officers and information regarding their interests in the proposed business combination will be included in the proxy statement for the proposed business combination when available.

Forward-looking Statements

Except for historical information contained herein, this press release contains certain “forward-looking statements” within the meaning of the federal U.S. securities laws with respect to the proposed business combination between Lakeshore and Nature’s Miracle, the benefits of the transaction, the amount of cash the transaction will provide Nature’s Miracle, the anticipated timing of the transaction, the services and markets of Nature’s Miracle, our expectations regarding future growth, results of operations, performance, future capital and other expenditures, competitive advantages, business prospects and opportunities, future plans and intentions, results, level of activities, performance, goals or achievements or other future events. These forward-looking statements generally are identified by words such as “anticipate,” “believe,” “expect,” “may,” “could,” “will,” “potential,” “intend,” “estimate,” “should,” “plan,” “predict,” or the negative or other variations of such statements, reflect our management’s current beliefs and assumptions and are based on the information currently available to our management. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual results or developments to differ materially from those expressed or implied by such forward-looking statements, including but not limited to: (i) the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect the price of Lakeshore’s securities; (ii) the risk that the transaction may not be completed by Lakeshore’s business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by Lakeshore; (iii) the failure to satisfy the conditions to the consummation of the transaction, including the approval of the business combination agreement by the stockholders of Lakeshore, the satisfaction of the minimum cash amount following any redemptions by Lakeshore’s public stockholders and the receipt of certain governmental and regulatory approvals; (iv) the lack of a third-party valuation in determining whether or not to pursue the proposed transaction; (v) the occurrence of any event, change or other circumstance that could give rise to the termination of the business combination agreement; (vi) the effect of the announcement or pendency of the transaction on Nature’s Miracle’s business relationships, operating results and business generally; (vii) risks that the proposed transaction disrupts current plans and operations of Nature’s Miracle; (viii) the outcome of any legal proceedings that may be instituted against Nature’s Miracle or Lakeshore related to the business combination agreement or the proposed transaction; (ix) the ability to maintain the listing of Lakeshore’s securities on a national securities exchange; (x) changes in the competitive industries in which Nature’s Miracle operates, variations in operating performance across competitors, changes in laws and regulations affecting Nature’s Miracle’s business and changes in the combined capital structure; (xi) the ability to implement business plans, forecasts and other expectations after the completion of the proposed transaction, and identify and realize additional opportunities; (xii) the risk of downturns in the market and Nature’s Miracle’s industry including, but not limited to, as a result of the COVID-19 pandemic; (xiii) costs related to the transaction and the failure to realize anticipated benefits of the transaction or to realize estimated pro forma results and underlying assumptions, including with respect to estimated stockholder redemptions; (xiv) risks and uncertainties related to Nature’s Miracle’s business, including, but not limited to risks relating to the uncertainty of the projected financial information with respect to Nature’s Miracle; risks related to Nature’s Miracle’s limited operating history, the roll-out of Nature’s Miracle’s business and the timing of expected business milestones; Nature’s Miracle’s ability to implement its business plan and scale its business; Nature’s Miracle’s ability to develop products and technologies that are more effective or commercially attractive than competitors’ products; Nature’s Miracle’s ability to maintain accelerate rate of growth recently due to lifestyle changes in the wake of COVID-19 pandemic; risks of increased costs as a result of being a public company; risks relating to Nature’s Miracle’s being unable to renew the leases of their facilities and warehouses; Nature’s Miracle’s ability to grow the size of its organization and management in response of the increase of sales and marketing infrastructure; risks relating to potential tariffs or a global trade war that could increase the cost of Nature’s Miracle’s products; risks relating to product liability lawsuits that could be brought against Nature’s Miracle;; Nature’s Miracle’s ability to formulate, implement and modify as necessary effective sales, marketing, and strategic initiatives to drive revenue growth; Nature’s Miracle’s ability to expand internationally; acceptance by the marketplace of the products and services that Nature’s Miracle markets; and government regulations and Nature’s Miracle’s ability to obtain applicable regulatory approvals and comply with government regulations. The foregoing list of factors is not exclusive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of proxy statement, when available, and other documents filed by Lakeshore from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and neither Nature’s Miracle nor Lakeshore assume any obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements. Neither Lakeshore nor Nature’s Miracle gives any assurance that either Lakeshore or Nature’s Miracle, or the combined company, will achieve its expectations.

Non-solicitation

This press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the potential business combination or any other matter and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of Lakeshore, Nature’s Miracle or the combined company, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended.

Contacts

info@nature-miracle.com

Source: Lakeshore Acquisition II Corp.

Monotype Acquires Berthold’s Renowned Typeface Inventory

One of the world’s first widely used sans-serif typefaces, Akzidenz-Grotesk, joins the Monotype family along with more than 700 historic typefaces from the Berthold library.

WOBURN, Mass., Aug. 26, 2022 /PRNewswire/ — Monotype® today announced that it has acquired the Berthold® inventory of typefaces with unique historical significance in the type industry.

The Akzidenz-Grotesk® typeface in use.
The Akzidenz-Grotesk® typeface in use.

The Berthold library is best known for its celebrated family of Akzidenz-Grotesk® typefaces, one of the world’s first widely used sans-serif typefaces which inspired many subsequent type designs including Helvetica®.  Akzidenz-Grotesk was created in 1896 and has been used by many of the world’s largest brands.

The original Berthold type foundry, H. Berthold AG, was founded in Berlin, Germany in 1858 and built a worldwide reputation for crafting high-quality typefaces. In 1997 Berthold Types Limited acquired the Berthold inventory as well as the distribution rights and maintenance of its digital typefaces. Along with their crown jewel Akzidenz-Grotesk, Berthold’s inventory includes much-loved typefaces such as Imago®, Cosmos®, Formata®, Block®, Solemnis® and City®.

Ninan Chacko, Monotype’s CEO said, “With this acquisition by Monotype, Berthold’s historic typefaces will become part of one of the world’s largest type foundries. Our stewardship will increase global visibility of Berthold’s inventory, celebrate its legacy, and get these important typefaces in the hands of more creative professionals. But more than that, this acquisition ensures iconic type families including Akzidenz-Grotesk, Imago, and Formata remain as accessible and relevant as other historic typeface families in the Monotype library such as Helvetica® Now, Gotham®, and Neue Frutiger®.”

Upon completion of the acquisition, the Berthold library of over 700 typefaces will continue to be sold through http://www.Bertholdtypes.com and http://www.Bertholdwebfonts.com.

Berthold’s library will also be delivered as a premium inventory collection through Monotype Fonts combining more than 36,000 typefaces with the expertise of the most sought-after foundries, type designers, and trusted and secure font management.

Deb Gonet, Vice President of the Monotype Studio said, “The H. Berthold AG type foundry was one of the largest and most successful type libraries known for high-quality typefaces. By adding Berthold’s classic type library to our Monotype Fonts offering, we are furthering our goal of giving creatives the best and broadest choice of typefaces all in one place.” 

About Monotype
Monotype creates brands that matter with type, technology, and expertise. The company partners with leading foundries to deliver the broadest inventory of high-quality typefaces in the world. Further information is available at www.monotype.com.

Follow Monotype on Twitter, Instagram and LinkedIn.

Monotype, Berthold, Akzidenz-Grotesk, Helvetica, Frutiger, Imago, Cosmos, Formata, Block, Solemnis, and City are trademarks of Monotype Imaging Inc. registered in the U.S. Patent and Trademark Office and may be registered in certain other jurisdictions. Gotham is a trademark of the Hoefler Type Foundry registered in the U.S. Patent and Trademark Office and may be registered in certain other jurisdictions. All other trademarks are the property of their respective owners.

©2022 Monotype Imaging Holdings Inc. All rights reserved.

Aiken Digital – SG / MY Join Forces with Onyx Island

SINGAPORE, June 20, 2022 /PRNewswire/ — Aiken Digital, a global growth agency that specialises in growth consulting, experience design, system development, creative & content, XB ecommerce and SaaS products, and Onyx Island, a leading digital experience agency in APAC, announced today on the completion of the merger between Aiken Digital and Onyx Island with a total workforce strength of 80 based in Singapore, Malaysia and Indonesia.

In connection with the merger, Onyx Island will become a wholly owned subsidiary of Aiken Digital. This merger will see a synergistic collaboration between the both agencies and evolve its offerings to serve the combined customer base of Aiken Digital & Onyx Island. Currently, the combined clientele includes Mastercard, L’Oréal, Luxottica, LVMH, Sotheby, L.D. Waxson, Beam Suntory, Cortina Watch, Philip Morris SG/MY, Salesforce APAC, NTUC and more.

From this merger, Aiken Digital will be known as Aiken Group, which will streamline its core businesses into 4 key business units as follows:

  1. Aiken Digital – Digital Consulting & Services
  2. Fixx Labs – Web 3.0 & Blockchain Solutions
  3. Social Commerce Cloud
  4. Esports & Gaming

Joseph Chua, CEO of Aiken Group, said, “Building upon our proven track record of successful M&A, this merger combines our expertise in consulting and digital experiences as we reimagine what we can deliver to customers as a leading global growth agency. We look forward to Onyx Island’s team joining Aiken Digital, further cultivating a shared culture of innovation and driving even greater value for Aiken Group’s stakeholders and partners.”

Danny Murong, Managing Director of Onyx Island, said, “Onyx Island has been reshaping the digital experience landscape for the past 10 years, helping our clients to improve the user’s experience through digital platforms/products. We stand for innovation and unwavering support of our clients and their business operations and now we are extending our commitment to exceptional service and innovation. Combining our assets and talented team with Aiken Digital’s experience in this field creates a remarkable growth agency to serve the needs of all our existing and future clients. Collectively, we will deliver even more value and innovation to customers, enabling them to thrive in this increasingly complex multi-cloud era.”

Danny Murong (pictured 5th from left), Zhi Wei Koh (pictured 3rd from left), Joshua Ooi (pictured 1st from right) & Wei Liang Lee (pictured 4th from right)
Danny Murong (pictured 5th from left), Zhi Wei Koh (pictured 3rd from left), Joshua Ooi (pictured 1st from right) & Wei Liang Lee (pictured 4th from right)

Following the closing of the merger, Aiken Digital will strengthen their ranks with a few key leadership positions within Singapore & Malaysia operations. The agency will appoint Danny Murong as the Chief Operating Officer (COO) – Aiken Group, Zhi Wei Koh as the Creative Director, Joshua Ooi as the Project Management Office Lead (PMO) and Wei Liang Lee as the Technical Lead.

About Aiken Digital

Aiken Digital is an established growth agency that focuses on developing technology solutions powered by AI to ignite a new generation of growth for companies.

Aiken has a global footprint with 7 offices worldwide in Malaysia, Singapore, China and UK. Founded in 2006 and head-quartered in China, Aiken serves multiple large clients such as Mastercard, Sotheby, L’Oréal, and more.

About Onyx Island

Onyx Island’s expertise in Digital Marketing, Social Media, UI/UX Design, Web Development, CRM Implementation & System Integration, Marketing & Sales Automation has helped key clients such as Beam Suntory, Cortina Watch, Luxottica, Philip Morris and Salesforce APAC build a positive user experience for their brands, fostering lasting and valuable relationships with their customers.

Founded in 2010, Onyx Island is headquartered in Singapore with regional operations in Bangladesh, Indonesia and Malaysia.

Trajan to acquire leading chromatography consumables and tools business building critical mass in the gas chromatography portfolio


Highlights

  • Trajan to acquire Chromatography Research Supplies, Inc. (CRS), a leading global manufacturer of high-quality analytical consumables
  • Provides Trajan with enhanced and extended production capabilities to service its growing gas chromatography business. Strengthens Trajan’s product portfolio particularly in the critical area of the gas chromatography inlet and sample introduction
  • Expands global infrastructure footprint with the acquisition of manufacturing real estate assets in the US
  • Follows three successful acquisitions and one strategic investment since listing on the ASX in June 2021
  • Acquisition delivers FY22 forecast revenues of US$14.1 million (A$20.1 million[1]) and EBITDA of US$4.2 million (A$6.0 million[1])[2], and estimated annual synergies of ~A$1.3 million[7]
  • Acquisition price of US$43.3 million (A$61.9 million[1]) implies ~9.5x FY22F EBITDA (pre synergies)[3]
  • Expected to deliver FY23F earnings per share accretion of >31%[1],[4],[5],[6] (excluding the impact of synergies) or >42% (including 100% of the pro forma impact of identified corporate savings and product line synergies[7])
  • Acquisition to be funded via a fully underwritten A$29.7 million institutional placement (Placement), A$20.0 million in acquisition debt financing through a facility with HSBC and $13.4 million from existing cash
  • Investor webinar to be held at 10:30am (AEST) Friday 17th June 2022. Register via this link.

MELBOURNE, Australia, June 19, 2022 /PRNewswire/ — Global analytical science and device company Trajan Group Holdings Limited (ASX: TRJ) (Trajan or the Company) has today announced the signing of a binding share purchase agreement and a real estate purchase agreement to acquire 100% of Chromatography Research Supplies, Inc. (CRS), a leading global manufacturer of high-quality analytical consumables based in Kentucky, USA.

Having operated for over 25 years, CRS is a leading manufacturer of electronic and manual crimping tools, gas filters, ferrules, and injection port septa. Its products are used in analytical laboratories and various other industries worldwide and are known for their quality, ease of use and high levels of support.

The acquisition is highly complementary to Trajan’s existing product portfolio in the analytical workflow and consolidates Trajan’s current market leading position in gas chromatography sample introduction, supporting the quality of flow path connection and sealing functions with two leading product lines – septa and ferrules. CRS has been a long-term supplier of consumables to Trajan since Trajan’s acquisition of SGE Analytical in 2013.

In addition, the acquisition extends Trajan’s portfolio via CRS’ other product lines. Such product lines include tools that relate to sealing sample vials which are highly complementary to the Trajan Soltec business acquired in late 2018, and coating technologies that align strongly with Trajan’s automation businesses Axel Semrau and LEAP Pal Parts which were both acquired in late 2021.

CRS has a track record of strong financial performance, with accelerated growth expected in FY22F, adding FY22 forecasted revenue of US$14.1 million (A$20.1 million[8]) and forecast EBITDA of US$4.2 million (A$6.0 million[8])[9]. The acquisition price of US$43.3 million (A$61.9 million[8]) implies a ~9.5x EV/FY22F EBITDA[10] on a pre synergies basis.  

Trajan has identified significant revenue and cost synergies as well as corporate savings realised from the date of acquisition and product line alignment, for total estimated annual synergy benefits of ~A$1.3 million[11], expected to ramp up within the first 2–3 years of ownership. Through the consolidation of current manufacturing facilities, Trajan can realise additional synergies over the medium to long term.

Stephen Tomisich, Chief Executive Officer and Managing Director of Trajan said: “The acquisition of CRS enhances multiple areas of our business and builds on our previous successful acquisitions to deliver comprehensive and best in class products in the analytical workflow.”

“Our market leadership in gas chromatography is enhanced with the addition of septa and ferrules components, as well as introducing a broader portfolio of products in other areas of the analytical workflow that build on our automation business.

As with our previous acquisitions, we have partnered with CRS for many years, understand their business, and know precisely where they fit within Trajan. The acquisition is earnings accretive and able to be rapidly integrated. Importantly, our acquisitions are building on capabilities to achieve our vision of personalised, preventative, data-based healthcare.”

Trajan has a proven framework to identify, acquire and integrate complementary businesses into its infrastructure. This framework involves a ‘founder friendly’ approach which is driven by deep industry relationships, targets solutions within the analytical workflow that have the potential to become industry best standard, is complementary to one or multiple business segments, and provides accretive and strategic opportunity to enhance shareholder value. 

Utilising this framework Trajan has, over the past 11 years, built a strong track record of delivering acquisitive and organic growth. That process has accelerated since the Company’s IPO in June 2021, having acquired laboratory automation business Axel Semrau GmbH in November 2021, microsampling business Neoteryx LLC in December 2021, and LEAP PAL Parts and Consumables in December 2021, as well as entered a strategic investment in consumer health monitoring with Humankind Ventures Ltd (trading as Forth) in November 2021.

Acquisition consideration

Trajan is acquiring CRS for US$43.3 million (A$61.9 million[12]) through a share purchase agreement and a real estate purchase agreement, the latter being for the purchase of the land and building from which CRS operates in Kentucky, USA.   

The Company will fund the acquisition of CRS via a fully underwritten A$29.7 million Placement to eligible institutional, sophisticated, and professional investors, an acquisition debt facility from HSBC of A$20.0 million and A$13.4 million from existing cash. Completion of Trajan’s acquisition of CRS is conditional on completion of the Placement and on Trajan satisfying customary conditions to drawdown under the HSBC acquisition financing facility.

The Placement is being issued at an offer price of $2.00 per new share (Offer Price), which represents a 11.1% discount to the last closing price of $2.25 on 16 June 2022.

The Placement will result in the issue of approximately 14.8 million new shares (New Shares), representing approximately 11.0% of Trajan’s existing shares on issue. The New Shares issued under the Placement will rank equally with existing Trajan shares at their date of issue.

Share Purchase Plan

Trajan will also offer eligible shareholders in Australia and New Zealand the opportunity to participate in a non-underwritten Share Purchase Plan (SPP). The SPP has a limit of $30,000 per eligible shareholder.

  • New Shares under the SPP will be issued at $2.00 per share, being the same price as the Offer Price under the Placement.
  • The SPP is being undertaken to raise up to $5.0 million[13].
  • Trajan intends to use the proceeds of the SPP to support the Company’s growth objectives through further strategic acquisitions and organic growth opportunities.
  • The SPP will open on Friday, 24 June 2022 and is expected to close at 5.00pm (AEST), Tuesday 12 July 2022.
  • Further details relating to the SPP will be provided to eligible shareholders in Australia and New Zealand in due course.

Canaccord Genuity (Australia) Limited and Ord Minnett Limited are joint lead managers and underwriters to the Placement and DLA Piper is acting as legal advisor to Trajan.

Indicative timetable

The timetable below is indicative only and subject to change. The Company reserves the right to alter the dates at its discretion and without prior notice, subject to the ASX Listing Rules and Corporations Act 2001 (Cth).

Event

Date[14]

SPP Record Date

7:00pm, Thursday, 16 June 2022

Offer announcement

Friday, 17 June 2022

Placement bookbuild opens

Friday, 17 June 2022

Placement bookbuild closes (all jurisdictions)

2:00pm, Friday, 17 June 2022

Announce completion of Placement and trading halt lifted

Monday, 20 June 2022

Settlement of New Securities under the Placement (DvP)

Wednesday, 22 June 2022

Allotment and normal trading of New Securities issued under the Placement

Thursday, 23 June 2022

SPP opens

Friday, 24 June 2022

SPP closes

5:00pm, Tuesday, 12 July 2022

SPP results announced to the ASX

Friday, 15 July 2022

SPP Securities issued

Tuesday, 19 July 2022

Authorised for ASX release by the Board of Trajan Group Holdings Limited.

[1] AUD/USD 0.70 based on assumed AUD/USD exchange rate

[2] CRS FY22F EBITDA includes a rent expense of US$228K

[3] EV / FY22F EBITDA multiple of 9.5x is based on an enterprise value of US$40.2 million (excluding the acquisition of freehold title to real estate owned by CSR for US$3.1 million) and an FY22F EBITDA of US$4.2 million converted to AUD at AUD/USD0.70

[4] Before one-off transaction and implementation costs

[5] Accretion assumes a pre-tax interest rate of 4%

[6] FY23F accretion assumes analyst consensus NPAT estimate of A$8.8m and CSR NPAT of A$4.7m (excluding corporate savings and product line synergies) and an effective tax rate of 20% for CSR based on Trajan management’s due diligence

[7] Refer to page 17 of the ASX Investor Presentation dated 17 June 2022

[8] AUD/USD 0.70 based on assumed AUD/USD exchange rate

[9] CRS FY22F EBITDA includes a rent expense of US$228K

[10] EV / FY22F EBITDA multiple of 9.5x is based on an enterprise value of US$40.2 million (excluding the acquisition of freehold title to real estate owned by CSR for US$3.1 million) and an FY22F EBITDA of US$4.2 million converted to AUD at AUD/USD0.70

[11] Refer to page 17 of the ASX Investor Presentation dated 17 June 2022

[12] AUD/USD 0.70 based on assumed AUD/USD exchange rate at time of completion

[13] The Company reserves its discretion regarding the final amount to be raised under the SPP

[14] The above timetable is indicative only and is subject to change without notice. All dates and times are Australian Eastern Standard Time (AEST).

About Trajan

Trajan is a global developer and manufacturer of analytical and life sciences products and devices founded to have a positive impact on human wellbeing through scientific measurement. These products and solutions are used in the analysis of biological, food, and environmental samples. Trajan has a portfolio and pipeline of new technologies which support the move towards decentralised, personalised data-based healthcare.

Trajan is a global organisation of 600 people with seven manufacturing sites across the US, Australia, Europe, and Malaysia, and operations in Australia, the US, Asia, and Europe.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/trajan-to-acquire-leading-chromatography-consumables-and-tools-business-building-critical-mass-in-the-gas-chromatography-portfolio-301570332.html